Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin
The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Background: Psilocybin is a serotonergic psychedelic found in “magic mushrooms” with a putative therapeutic potential for treatment-resistant depression, anxiety, obsessive-compulsive disorder, and addiction. In rodents, psilocybin acutely induces plasticity-related immediate early genes in cortical tissue; however, studies into the effects on subcortical regions, of different doses, and the subsequent translation of corresponding proteins are lacking. Methods: We examined the acute effects of a single administration of psilocybin (0.5–20 mg/kg) on the expression of selected genes in the prefrontal cortex and hippocampus. In total, 46 target genes and eight reference genes were assessed using real-time quantitative polymerase chain reaction. Corresponding protein levels of the three most commonly regulated genes were assessed using Western blotting. Results: In the prefrontal cortex, psilocybin increased the expression of Cebpb, c-Fos, Dups1, Fosb, Junb, Iκβ-α, Nr4a1, P11, Psd95, and Sgk1, and decreased the expression of Clk1. In the hippocampus, psilocybin strongly increased the expression of Arrdc2, Dusp1, Iκβ-α, and Sgk1 in a dose-dependent manner, and decreased the expression of Arc, Clk1, Egr2, and Ptgs2. Protein levels of Sgk1, Dusp1, and Iκβ-α showed only partial agreement with transcriptional patterns, stressing the importance of assessing downstream translation when investigating rapid gene responses. Conclusion: The present study demonstrates that psilocybin rapidly…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Psilocybin stimulated the expression of IEGs in the PFC, and induced stimulating and inhibiting effects in the hippocampus (55).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [55]
In the citing paper
“Moreover, in both areas, most IEGs were affected in a dose-dependent manner, with higher doses inducing more stimulation of gene expression (55).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [55]
In the citing paper
“A single dose of psilocybin (0.5, 1, 2, 4, 8, 14, 20 mg/kg, i.p.) administered to rats (n = 10) altered the expression of plasticity-promoting genes in the prefrontal cortex (PFC) and hippocampus, 90 min after treatment (55).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [55]
In the citing paper
“Findings from in vivo studies investigating acute effects of a single dose of 5-MeO-DMT, DMT, psilocybin, and LSD (37%) suggest altered cellular plasticity of structural and functional nature (54–60).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [55]
In the citing paper
“preclinical evidence suggests a dose-dependent effect on increases in the expression of some neuroplasticity-related genes induced by serotonergic psychedelics [73–75]”
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1×
“This incongruity is not surprising considering that translation is regulated by a plethora of post-transcriptional mechanisms, and the general correlation between transcriptional and translational responses is usually modest (Schwanhausser et al., 2011).”
BackgroundA Simple Practice Guide for Dose Conversion between Animals and Human
Nair, A., & Jacob, S. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.177703 · Cited by 6,174
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 1×
“, 1985) also implicated in the pathophysiology of depression (Price and Drevets, 2010).”
BackgroundCarhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
MAPK cascade signalling and synaptic plasticity
Thomas, G. M., & Huganir, R. L. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1346 · Cited by 1,454
PSD-95 Involvement in Maturation of Excitatory Synapses
El-Husseini, A. E.-D., Schnell, E., Chetkovich, D. M., Nicoll, R. A., & Bredt, D. S. (2000) · Science · doi:10.1126/science.290.5495.1364 · Cited by 1,303 · cited 1×
“, 2003; Lopez-Gimenez and Gonzalez-Maeso, 2018); (c) transcriptional regulation of synaptic plasticity (Alberini, 2009; El-Husseini et al., 2000); or (d) transcriptional effects of anti-depressive treatments (Bramham et al.”
BackgroundPsychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 2×
“In humans, these acute effects are followed by long-lasting positive effects on clinical symptoms (Bogenschutz et al., 2015; Carhart-Harris et al., 2016, 2018; Griffiths et al., 2016; Grob et al., 2011; Johnson et al., 2014, 2017; Moreno et al., 2006; Ross et al., 2016) and psychological features (Erritzoe et al.”
BackgroundPsilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
Transcription Factors in Long-Term Memory and Synaptic Plasticity
Alberini, C. M. (2009) · Physiological Reviews · doi:10.1152/physrev.00017.2008 · Cited by 991 · cited 3×
“of immediate early genes (IEGs) and other functionally important genes required for synaptic plasticity (Alberini, 2009).”
BackgroundPsilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914
Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108094300 · Cited by 905
Pazos, A., Cortés, R., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90857-1 · Cited by 824
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789 · cited 2×
“In humans, these acute effects are followed by long-lasting positive effects on clinical symptoms (Bogenschutz et al., 2015; Carhart-Harris et al., 2016, 2018; Griffiths et al., 2016; Grob et al., 2011; Johnson et al., 2014, 2017; Moreno et al., 2006; Ross et al., 2016) and psychological features (Erritzoe et al.”
BackgroundInvited review c-Fos as a transcription factor: a stressful (re)view from a functional map
Kovács, K. J. (1998) · Neurochemistry International · doi:10.1016/s0197-0186(98)00023-0 · Cited by 740 · cited 1×
“c-Fos has been widely used as a marker of neuronal activity (Kovacs, 1998), and the present findings therefore indicate that psilocybin induces strong neuronal activation in the PFC, but not in the HIP, consistent with electrophysiological studies and receptor distributions between regions (Aghajanian and Marek, 1999;…”
ResultLong-term follow-up of psilocybin-facilitated smoking cessation
Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1170135 · Cited by 696
Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase
Keyse, S. M., & Emslie, E. A. (1992) · Nature · doi:10.1038/359644a0 · Cited by 636
Roles for NF-κB in nerve cell survival, plasticity, and disease
Mattson, M. P., & Meffert, M. K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401837 · Cited by 595
Translational Regulatory Mechanisms in Persistent Forms of Synaptic Plasticity
Kelleher, R. J., Govindarajan, A., & Tonegawa, S. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.013 · Cited by 592 · cited 1×
“Although the acute effects of psilocybin may be explained by direct 5-HT receptor activation, the long-lasting changes in brain network connectivity and underlying synaptic plasticity require downstream transcriptional effects (Alberini, 2009) and subsequent regulation of protein translation (Kelleher et al., 2004).”
BackgroundPsilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587 · cited 1×
“, 2011), paralleled by lasting changes in brain connectivity (Carhart-Harris et al., 2017).”
BackgroundStuderus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110382466 · Cited by 532
C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia
Alberini, C. M., Ghirardl, M., Metz, R., & Kandel, E. R. (1994) · Cell · doi:10.1016/0092-8674(94)90386-7 · Cited by 523
Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., Johansen, S. S., Lehel, S., Linnet, K., Svarer, C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0324-9 · Cited by 517
The Immediate Early Gene Arc/Arg3.1: Regulation, Mechanisms, and Function
Bramham, C. R., Worley, P. F., Moore, M. J., & Guzowski, J. F. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3864-08.2008 · Cited by 484
Vaidya, V. A., Marek, G. J., Aghajanian, G. K., & Duman, R. S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02785.1997 · Cited by 479
A negative regulator of MAP kinase causes depressive behavior
Duric, V., Banasr, M., Licznerski, P., Schmidt, H. D., Stockmeier, C. A., Simen, A. A., Newton, S. S., & Duman, R. S. (2010) · Nature Medicine · doi:10.1038/nm.2219 · Cited by 412 · cited 2×
“Paradoxically, each of these genes has been linked to both promotion and deterioration of synaptic plasticity, possibly depending on whether the activation is acute or chronic (Alberini et al., 1994; Anacker et al., 2013; Bridi et al., 2017; Duric et al., 2010; Jeanneteau et al., 2010, 2018; Thomas and Huganir, 2004).”
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Rickli, A., Moning, O. D., Hoener, M. C., & Liechti, M. E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.001 · Cited by 379
Aghajanian, G. K., & Marek, G. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01224-x · Cited by 374
A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK?
Knapska, E., & Kaczmarek, L. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.007 · Cited by 370
A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System
Beliveau, V., Ganz, M., Feng, L., Ozenne, B., Højgaard, L., Fisher, P. M., Svarer, C., Greve, D. N., & Knudsen, G. M. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2830-16.2016 · Cited by 368 · cited 2×
“We focused on the PFC, an area with dense 5-HT2A receptor expression (Beliveau et al., 2017; Pazos and Palacios, 1985; Pazos et al., 1985), and an important locus for serotonergic psychedelics and antidepressant drug effects (Martin and Nichols, 2016), and the HIP, an area with a higher proportion of 5-HT1A receptors…”
BackgroundKometer, M., Schmidt, A., Jancke, L., & Vollenweider, F. X. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3007-12.2013 · Cited by 355
Anacker, C., Cattaneo, A., Musaelyan, K., Zunszain, P. A., Horowitz, M., Molteni, R., Luoni, A., Calabrese, F., Tansey, K., Gennarelli, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300886110 · Cited by 319 · cited 1×
“Paradoxically, each of these genes has been linked to both promotion and deterioration of synaptic plasticity, possibly depending on whether the activation is acute or chronic (Alberini et al., 1994; Anacker et al., 2013; Bridi et al., 2017; Duric et al., 2010; Jeanneteau et al., 2010, 2018; Thomas and Huganir, 2004).”
BackgroundHallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_478 · Cited by 299
González-Maeso, J., Yuen, T., Ebersole, B. J., Wurmbach, E., Lira, A., Zhou, M., Weisstaub, N., Hen, R., Gingrich, J. A., & Sealfon, S. C. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08836.2003 · Cited by 297
Reference genes for normalization: A study of rat brain tissue
Bonefeld, B. E., Elfving, B., & Wegener, G. (2008) · Synapse · doi:10.1002/syn.20496 · Cited by 267
Self-citationEffects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12904 · Cited by 267
Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA
Mithoefer, M. C., Grob, C. S., & Brewerton, T. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00576-3 · Cited by 239
Conserved principles of mammalian transcriptional regulation revealed by RNA half-life
Friedel, C. C., Dölken, L., Ruzsics, Z., Koszinowski, U. H., & Zimmer, R. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp542 · Cited by 230
Béïque, J.-C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700436104 · Cited by 229 · cited 1×
“Second, the present study analyzed the total lysate of the investigated brain regions, which may have led to false negative findings, as the effects of psilocin may be mediated by a small subset (“trigger population”) of neurons (Beique et al., 2007; Martin and Nichols, 2016).”
BackgroundHalberstadt, A. L., Koedood, L., Powell, S. B., & Geyer, M. A. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110388326 · Cited by 213
Hibicke, M., Landry, A. N., Kramer, H. M., Talman, Z. K., & Nichols, C. D. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00493 · Cited by 205 · cited 1×
“First, the translationally relevant dose (in rodents) for the putative therapeutic effects of psilocybin is yet to be fully established (Hibicke and Nichols, 2020; Hibicke et al., 2020; Jefsen et al., 2019; Meinhardt et al., 2020).”
BackgroundConti, B., Maier, R., Barr, A. M., Morale, M. C., Lu, X., Sanna, P. P., Bilbe, G., Hoyer, D., & Bartfai, T. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001897 · Cited by 204
p11 and its role in depression and therapeutic responses to antidepressants
Svenningsson, P., Kim, Y., Warner-Schmidt, J., Oh, Y.-S., & Greengard, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3564 · Cited by 174
Significance of SGK1 in the regulation of neuronal function
Lang, F., Strutz-Seebohm, N., Seebohm, G., & Lang, U. E. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.190926 · Cited by 170
Kurrasch-Orbaugh, D. M., Watts, V. J., Barker, E. L., & Nichols, D. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042184 · Cited by 166
Sheldon, P. W., & Aghajanian, G. K. (1990) · Brain Research · doi:10.1016/0006-8993(90)91199-q · Cited by 164
Nichols, C. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00405-5 · Cited by 163 · cited 1×
“0 mg/kg) rapidly induces IEG expression in the prefrontal cortex (PFC), hippocampus (HIP), and midbrain (MB) (Nichols and Sanders-Bush, 2002; Nichols et al., 2003).”
BackgroundThe MAP kinase phosphatase MKP-1 regulates BDNF-induced axon branching
Jeanneteau, F., Deinhardt, K., Miyoshi, G., Bennett, A. M., & Chao, M. V. (2010) · Nature Neuroscience · doi:10.1038/nn.2655 · Cited by 163
Johnson, M. P., Loncharich, R. J., Baez, M., & Nelson, D. L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09924-9 · Cited by 104
Jeanneteau, F., Barrère, C., Vos, M., De Vries, C. J. M., Rouillard, C., Levesque, D., Dromard, Y., Moisan, M.-P., Duric, V., Franklin, T. C., et al. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2793-17.2017 · Cited by 91
Sex differences and serotonergic mechanisms in the behavioural effects of psilocin
Tylš, F., Páleníček, T., Kadeřábek, L., Lipski, M., Kubešová, A., & Horáček, J. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000198 · Cited by 86
Martin, D. A., & Nichols, C. D. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.049 · Cited by 86
Nichols, C. D., Garcia, E. E., & Sanders-Bush, E. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00029-9 · Cited by 82
(2013) · Medicinal Chemistry Research · doi:10.1007/44.1554-8120 · Cited by 81
Karaki, S., Becamel, C., Murat, S., Mannoury la Cour, C., Millan, M. J., Prézeau, L., Bockaert, J., Marin, P., & Vandermoere, F. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036558 · Cited by 74
Askari, S., & Salpekar, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00080-9 · Cited by 74
Almaula, N., Ebersole, B. J., Ballesteros, J. A., Weinstein, H., & Sealfon, S. C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09149-7 · Cited by 73
Pharmacological Activators of the NR4A Nuclear Receptors Enhance LTP in a CREB/CBP-Dependent Manner
Bridi, M. S., Hawk, J. D., Chatterjee, S., Safe, S. H., & Abel, T. G. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.253 · Cited by 66
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat
Jefsen, O., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D. J., Wegener, G., & Müller, H. K. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.15 · Cited by 63
Self-citationNichols, C. D., & Sanders‐Bush, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02515.x · Cited by 62 · cited 1×
“For example, in a study of the effects of LSD on gene expression patterns in the rat PFC, HIP, and MB, 10 genes were found to be regulated (c-Fos, Arc, Ania3, Iκβ-α, Egr2, Nr4a3, Sgk1, Cebpb, Dusp1, and Arrdc2), using RNA microarrays followed by either RNase protection assays (Nichols and SandersBush, 2002) or real-ti…”
MethodBenekareddy, M., Nair, A. R., Dias, B. G., Suri, D., Autry, A. E., Monteggia, L. M., & Vaidya, V. A. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000168 · Cited by 45
Koga, S., Kojima, S., Kishimoto, T., Kuwabara, S., & Yamaguchi, A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.12.004 · Cited by 43
Johnson, M. P., Baez, M., Kursar, J. D., & Nelson, D. L. G. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00073-c · Cited by 42
Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action
Ficek, J., Zygmunt, M., Piechota, M., Hoinkis, D., Rodriguez Parkitna, J., Przewlocki, R., & Korostynski, M. (2016) · BMC Genomics · doi:10.1186/s12864-016-2713-3 · Cited by 42 · cited 1×
“, 2000); or (d) transcriptional effects of anti-depressive treatments (Bramham et al., 2008; Conti et al., 2007; Ficek et al., 2016; Jeanneteau et al., 2010, 2018; Svenningsson et al., 2013).”
BackgroundHibicke, M., & Nichols, C. D. (2020) · The FASEB Journal · doi:10.1096/fasebj.2020.34.s1.02912 · Cited by 10
Research works printed but not linked: 2
- Almaula N, 1996, Mol Pharmacol, 50, 34
- Johnson MP, 1994, Mol Pharmacol, 45, 277
Cited by
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069100 · Cited by 325
Towards an understanding of psychedelic-induced neuroplasticity
Calder, A. E., & Hasler, G. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01389-z · Cited by 313
“Similarly, DOI failed to enhance expression of Arc in the hippocampus [106].”
BackgroundInfluentialNeuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276
de Vos, C. M. H., Mason, N. L., & Kuypers, K. P. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724606 · Cited by 269
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Metadata
- Authors
- Jefsen, O. H., Elfving, B., Wegener, G., & Müller, H. K.
- Affiliations
- Aarhus University (DK)
- Corresponding author
- Jefsen, Oskar Hougaard
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2020-11-04
- Volume
- 35
- Issue
- 4
- Pages
- 483-493
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W3094714065
- Semantic Scholar
- bed49b948ad75bafb93f76f7d68ec15f3dd554c7
- Cited by
- 127
- References
- 71
- Citations by year
- 2026: 21 · 2025: 26 · 2024: 31 · 2023: 20 · 2022: 11 · 2021: 16 · 2020: 1
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Det Frie Forskningsråd (DFF-7025-00041)
- Solar Fonden af 1978
- Fonden til Lægevidenskabens Fremme
- Direktør Emil C. Hertz og Hustru Inger Hertz Fond
- Dagmar Marshalls Fond
- Torben og Alice Frimodts Fond
- Lundbeckfonden (R-197-2016-1730)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- psilocybin, psychedelics, transcriptional regulation, prefrontal cortex, hippocampus, immediate early genes, neuroplasticity, gene expression, mRNA translation, SGK1, MKP-1, Arc, CLK1, dose-dependent effects, serotonergic psychedelics
- MeSH terms
- Animals, Cytoskeletal Proteins, Dose-Response Relationship, Drug, Gene Expression Regulation, Hallucinogens, Hippocampus, Nerve Tissue Proteins, Neuronal Plasticity, Psilocybin, Genes, fos, Rats, Sprague-Dawley, Prefrontal Cortex, Genes, Immediate-Early, Rats, Early Growth Response Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.